Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2001 1
2003 1
2004 1
2008 1
2009 2
2013 1
2014 1
2017 1
2018 1
2023 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
The UK nationwide observational study of colon capsule: CAP ACCESS study.
Lei II, Ibrahim H, Jardine R, Koulaouzidis A, Beshyah W, Mcgreevy C, Arefin A, Jarocki M, Ambler T, Kiladze G, Hunt C, Pillay L, Patel S, Nair SS, Nizar ZY, Fisher I, Arasaradnam RP; CAP ACCESS study group. Lei II, et al. Dig Liver Dis. 2025 Jul;57(7):1465-1472. doi: 10.1016/j.dld.2025.04.010. Epub 2025 May 13. Dig Liver Dis. 2025. PMID: 40368700 Free article.
Erratum to: Vascular access registry of Serbia: a 4-year experience.
Jemcov T, Dimkovic N, Jovanovic D, Lazarevic T, Mitic I, Naumovic R, Simic-Ogrizovic S, Velickovic R; Vascular Access Study Group. Jemcov T, et al. Int Urol Nephrol. 2017 Feb;49(2):367. doi: 10.1007/s11255-017-1511-4. Int Urol Nephrol. 2017. PMID: 28120183 No abstract available.
Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels.
Ballantyne CM, Andrews TC, Hsia JA, Kramer JH, Shear C; ACCESS Study Group. Atorvastatin Comparative Cholesterol Efficacy and Safety Study. Ballantyne CM, et al. Am J Cardiol. 2001 Aug 1;88(3):265-9. doi: 10.1016/s0002-9149(01)01638-1. Am J Cardiol. 2001. PMID: 11472705 Clinical Trial.
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.
Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, Jauregui L, Krell K, Pachl J, Takahashi T, Peckelsen C, Cordasco E, Chang CS, Oeyen S, Aikawa N, Maruyama T, Schein R, Kalil AC, Van Nuffelen M, Lynn M, Rossignol DP, Gogate J, Roberts MB, Wheeler JL, Vincent JL; ACCESS Study Group. Opal SM, et al. JAMA. 2013 Mar 20;309(11):1154-62. doi: 10.1001/jama.2013.2194. JAMA. 2013. PMID: 23512062 Clinical Trial.
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial.
Shinohara Y, Nishimaru K, Sawada T, Terashi A, Handa S, Hirai S, Hayashi K, Tohgi H, Fukuuchi Y, Uchiyama S, Yamaguchi T, Kobayashi S, Kondo K, Otomo E, Gotoh F; S-ACCESS Study Group. Shinohara Y, et al. Stroke. 2008 Jun;39(6):1827-33. doi: 10.1161/STROKEAHA.107.505131. Epub 2008 Apr 3. Stroke. 2008. PMID: 18388340 Clinical Trial.
13 results